½ÃÀ庸°í¼­
»óǰÄÚµå
1597128

À¯·´ÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå ¿¹Ãø : Áö¿ªº° ºÐ¼®-Á¦Ç°º°, ÃÖÁ¾ »ç¿ëÀÚº°(-2031³â)

Europe Blood Gas and Electrolyte Analyzer Market Forecast to 2031 - Regional Analysis - by Product and End User

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Insight Partners | ÆäÀÌÁö Á¤º¸: ¿µ¹® 83 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

À¯·´ÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀåÀº 2023³â¿¡ 7¾ï 268¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2031³â±îÁö´Â 10¾ï 7,496¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2023³âºÎÅÍ 2031³â±îÁöÀÇ CAGRÀº 5.5%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

POC(Point of Care) Áø´ÜÀÇ º¸±ÞÀÌ À¯·´ÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀåÀ» °ßÀÎ

Æ÷ÀÎÆ® ¿Àºê ÄÉ¾î °Ë»ç´Â ȯÀÚ°¡ ÀÖ´Â °÷À̳ª ±× ±Ùó¿¡¼­ Áï½Ã Áø´Ü °á°ú¸¦ Á¦°øÇÏ¿© ½Å¼ÓÇÑ ÀÓ»óÀû ÀÇ»ç°áÁ¤, ¿öÅ©Ç÷οìÀÇ ÇÕ¸®È­, ȯÀÚÀÇ °á°ú °³¼±À» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ½Ã±âÀûÀýÇÑ °³ÀÔ, È¿À²ÀûÀÎ Áø´Ü ÇÁ·Î¼¼½º, °³ÀÎÈ­µÈ ÀÇ·á Á¦°ø¿¡ ´ëÇÑ ¿ä±¸°¡ ºÐ»êÇü °Ë»ç ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â´Â ÀÇ·áÁ¾»çÀÚ°¡ ȯÀÚÀÇ º£µå»çÀ̵å, ÀÀ±Þ½Ç ¶Ç´Â ¿ø°ÝÁö¿¡¼­ Áß¿äÇÑ Áø´Ü °Ë»ç¸¦ ¼öÇàÇÒ ¼ö ÀÖ°Ô Çϰí, Ç÷¾×°¡½º ¸Å°³ º¯¼ö, ÀüÇØÁú ¼öÁØ ¹× »ê¿°±â »óŸ¦ ÇöÀå¿¡¼­ ½±°Ô Æò°¡ÇÒ ¼ö ÀÖ°Ô ÇÕ´Ï´Ù. Æ÷ÀÎÆ® ¿Àºê ÄÉ¾î ºÐ¼® ÀåÄ¡¿¡ ´ëÇÑ Á¢±Ù¼º°ú Áï°¢¼ºÀ» ÅëÇØ ÀÓ»óÀÇ´Â ÀûÀýÇÑ Ä¡·á¸¦ ½Å¼ÓÇÏ°Ô ½ÃÀÛÇϰí, ȯÀÚÀÇ ¹ÝÀÀÀ» ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇϰí, ±Þ¼º±â ÀÇ·á¿¡¼­ ÀÓ»óÀû ÀÇ»ç °áÁ¤À» ÃÖÀûÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù.

POC(Point of Care) Áø´ÜÀ¸·ÎÀÇ ½ÃÇÁÆ®´Â Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±âÀÇ ±â¼úÀû Áøº¸¸¦ ÃËÁøÇϰí Á¤È®ÇÏ°í ½Å¼ÓÇÑ °á°ú¸¦ Á¦°øÇÏ´Â ÄÞÆÑÆ®Çϰí ÀÚµ¿È­µÈ »ç¿ëÇϱ⠽¬¿î ÀåÄ¡¿¡ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù. ºÐ¼®±â´Â ÷´Ü ±â¼úÀ» Ȱ¿ëÇÏ¿©, Á¤È®ÇÑ ÃøÁ¤, ǰÁú º¸Áõ ±â´É, µ¥ÀÌÅÍ °ü¸® ¹× ÀüÀÚ ÀÇ·á ±â·Ï°úÀÇ ÅëÇÕÀ» À§ÇÑ ¿¬°á ¿É¼ÇÀ» Á¦°øÇÕ´Ï´Ù. Æ÷ÀÎÆ® ¿Àºê ÄÉ¾î ºÐ¼®±â¸¦ ÇコÄɾîÀÇ ¿öÅ©Ç÷ο쿡 ¿øÈ°ÇÏ°Ô ÅëÇÕÇÔÀ¸·Î½á ¾÷¹« È¿À²À» ³ôÀÌ°í °á°ú±îÁöÀÇ ¼Ò¿ä ½Ã°£À» ´ÜÃàÇÏ¿© ȯÀÚ ÄɾîÀÇ ÀüüÀûÀÎ ÁúÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÅëÇÕÀº Áø´Ü °úÁ¤¿¡ Çõ¸íÀ» °¡Á®¿À°í, °Ç°­ °ü¸® Á¦°øÀÚ¿¡°Ô Áï°¢ÀûÀÎ µ¥ÀÌÅÍ ÀλçÀÌÆ®¸¦ Á¦°øÇϸç, ȯÀÚ °ü¸®¿Í ÀÓ»óÀû ÀÇ»ç °áÁ¤À» °­È­ÇÏ´Â Àû½Ã °³ÀÔÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÀÌó·³ ÇコÄɾî ÇöÀåÀÌ Æ÷ÀÎÆ® ¿Àºê ÄÉ¾î °Ë»çÀÇ ÀÌÁ¡À» ¹Þ¾ÆµéÀ̸鼭 ÈÞ´ë¿ëÀ¸·Î »ç¿ëÇÏ±â Æí¸®ÇÑ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

À¯·´ÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå °³¿ä

À¯·´ÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå¿¡´Â ÇÁ¶û½º, µ¶ÀÏ, ¿µ±¹, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, ±âŸ À¯·´ÀÇ ¿¬°á½ÃÀåÀÌ Æ÷ÇԵ˴ϴÙ. À¯·´Àº ¼¼°èÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå¿¡¼­ Áß¿äÇÑ À§Ä¡¸¦ Â÷ÁöÇϰí ÀÖÀ¸¸ç, ¿¹Ãø ±â°£ µ¿¾È Ȱ¹ßÇÑ ¼ºÀå·üÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ¹è°æ¿¡´Â ¸¸¼ºÁúȯÀÇ Áõ°¡¿Í ´Ù¾çÇÑ ÀÓ»ó ¿ëµµ¿¡ ´ëÇÑ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±âÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ´Â °ÍÀÌ ÀÖÀ¸¸ç, À̰ÍÀÌ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

À¯·´ÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå ¼öÀÍ ¹× ¿¹Ãø(±Ý¾×)(-2031³â)

À¯·´ÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå ¼¼ºÐÈ­

À¯·´ÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀåÀº Á¦Ç°, ÃÖÁ¾ »ç¿ëÀÚ, ±¹°¡·Î ºÐ·ùµË´Ï´Ù.

Á¦Ç°º°·Î À¯·´ÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀåÀº Ç÷¾×°¡½º ºÐ¼®±â, ÀüÇØÁú ºÐ¼®±â, º¹ÇÕ ºÐ¼®±â, ±âŸ·Î ºÐ·ùµË´Ï´Ù. 2023³â¿¡´Â º¹ÇÕ ºÐ¼®±â°¡ ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

ÃÖÁ¾ »ç¿ëÀÚº°·Î´Â À¯·´ÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀåÀº º´¿ø ¹× Áø·á¼Ò, ÀÓ»ó ¹× Áø´Ü°Ë»ç½Ç, ÀçÅÃÀÇ·á, ±âŸ µîÀ¸·Î ºÐ·ùµË´Ï´Ù. 2023³â¿¡´Â ÀÓ»ó ¹× Áø´Ü°Ë»ç½Ç ºÎ¹®ÀÌ ÃÖ´ë ½ÃÀåÁ¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

±¹°¡º°·Î´Â À¯·´ÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀåÀº µ¶ÀÏ, ¿µ±¹, ÇÁ¶û½º, ½ºÆäÀÎ, ÀÌÅ»¸®¾Æ, ±âŸ À¯·´À¸·Î ±¸ºÐµË´Ï´Ù. 2023³â À¯·´ÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå Á¡À¯À²Àº µ¶ÀÏÀÌ µ¶Á¡Çß½À´Ï´Ù.

Abbott Laboratories, Dalko Diagnostics Private Limited, Erba Diagnostics Mannheim GmbH, Hoffmann-La Roche Ltd, Medica Corporation, Nova Biomedical Corporation, Siemens Healthineers AG, Werfen SA, Radiometer Medical ApS, Sensa Core Medical Instrumentation Pvt Ltd.´Â À¯·´ÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå¿¡¼­ »ç¾÷À» Àü°³Çϰí ÀÖ´Â ÁÖ¿ä ±â¾÷ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ÁÖ¿ä ÀλçÀÌÆ®

Á¦3Àå Á¶»ç ¹æ¹ý

  • Á¶»ç ¹üÀ§
  • 2Â÷ Á¶»ç
  • 1Â÷ Á¶»ç

Á¦4Àå À¯·´ÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå »óȲ

  • °³°ü
  • PEST ºÐ¼®

Á¦5Àå À¯·´ÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå : ÁÖ¿ä ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • º´¿øÀÇ ±¸±Þ À¯´Ö¿¡¼­ÀÇ È¯ÀÚ¼ö Áõ°¡
    • POC(Point of Care) Áø´ÜÀÇ Ã¤¿ë Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ºÐ¼® ÀåÄ¡ÀÇ °íºñ¿ë
  • ½ÃÀå ±âȸ
    • ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ
  • ÇâÈÄÀÇ µ¿Çâ
    • Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±âÀÇ ÀÚµ¿È­¿Í ÀΰøÁö´ÉÈ­
  • ¼ºÀå ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎÀÇ ¿µÇâ

Á¦6Àå À¯·´ÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå ºÐ¼®

  • À¯·´ÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå ¼öÀÍ(2021-2031³â)
  • Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå ¿¹Ãø ºÐ¼®

Á¦7Àå À¯·´ÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå ºÐ¼® : Á¦Ç°º°

  • Ç÷¾×°¡½º ºÐ¼®±â
  • ÀüÇØÁú ºÐ¼®±â
  • º¹ÇÕ ºÐ¼®±â
  • ±âŸ

Á¦8Àå À¯·´ÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°

  • º´¿ø ¹× Áø·á¼Ò
  • ÀÓ»ó ¹× Áø´Ü°Ë»ç½Ç
  • ÀçÅà ġ·á
  • ±âŸ

Á¦9Àå À¯·´ÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå : ±¹°¡º° ºÐ¼®

  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´

Á¦10Àå ¾÷°è Á¤¼¼

  • À¯±âÀû ¼ºÀå Àü·«
  • ºê·£µå Á¡À¯À² ¹× ¼öÀÍ(2022³â)

Á¦11Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Abbott Laboratories
  • Dalko Diagnostics Private Limited
  • Erba Diagnostics Mannheim GmbH
  • Hoffmann-La Roche Ltd
  • Medica Corporation
  • Nova Biomedical Corporation
  • Siemens Healthineers AG
  • Werfen SA
  • Radiometer Medical ApS
  • Sensa Core Medical Instrumentation Pvt Ltd

Á¦12Àå ºÎ·Ï

AJY 24.12.05

The Europe blood gas and electrolyte analyzer market was valued at US$ 702.68 million in 2023 and is projected to reach US$ 1,074.96 million by 2031; it is estimated to record a CAGR of 5.5% from 2023 to 2031.

Rising Adoption of Point-of-Care Diagnostics Drives Europe Blood Gas and Electrolyte Analyzer Market

Point-of-care testing offers immediate diagnostic results at or near the patient's location, enabling rapid clinical decision-making, streamlined workflows, and enhanced patient outcomes. The need for timely interventions, efficient diagnostic processes, and personalized healthcare delivery fuels the demand for decentralized testing solutions. Blood gas and electrolyte analyzers allow healthcare providers to perform critical diagnostic tests at the patient's bedside, in the emergency department or in remote settings, facilitating on-the-spot assessment of blood gas parameters, electrolyte levels, and acid-base status. The accessibility and immediacy of point-of-care analyzers empower clinicians to initiate appropriate treatments promptly, monitor patient responses in real time, and optimize clinical decision-making in acute care scenarios.

The shift toward point-of-care diagnostics drives technological advancements in blood gas and electrolyte analyzers, focusing on compact, automated, and easy-to-use devices that deliver accurate and fast results. The analyzers leverage advanced technologies to provide precise measurements, quality assurance features, and connectivity options for data management and integration with electronic health records. The seamless integration of point-of-care analyzers into healthcare workflows enhances operational efficiency, reduces turnaround times for results, and improves the overall quality of patient care. The integration revolutionizes the diagnostic process, empowering healthcare providers with immediate data insights and enabling timely interventions that enhance patient management and clinical decision-making. Thus, as healthcare settings embrace the advantages of point-of-care testing, the demand for portable and user-friendly blood gas and electrolyte analyzers is rising.

Europe Blood Gas and Electrolyte Analyzer Market Overview

The Europe blood gas and electrolyte analyzer market includes the consolidated markets for France, Germany, the UK, Italy, Spain, and the Rest of Europe. Europe holds a significant position in the global blood gas and electrolyte analyzer market and is expected to record a vigorous growth rate during the forecast period. The market growth is attributed to the rising incidences of chronic diseases and increased adoption of blood gas and electrolyte analyzers for various clinical applications, which is expected to drive the market growth.

Europe Blood Gas and Electrolyte Analyzer Market Revenue and Forecast to 2031 (US$ Million)

Europe Blood Gas and Electrolyte Analyzer Market Segmentation

The Europe blood gas and electrolyte analyzer market is categorized into product, end user, and country.

Based on product, the Europe blood gas and electrolyte analyzer market is categorized into blood gas analyzer, electrolyte analyzer, combined analyzer, and others. The combined analyzer segment held the largest market share in 2023.

By end user, the Europe blood gas and electrolyte analyzer market is segmented into hospitals and clinics, clinical and diagnostic laboratories, homecare, and others. The clinical and diagnostic laboratories segment held the largest market share in 2023.

By country, the Europe blood gas and electrolyte analyzer market is segmented into Germany, the UK, France, Spain, Italy, and the Rest of Europe. Germany dominated the Europe blood gas and electrolyte analyzer market share in 2023.

Abbott Laboratories, Dalko Diagnostics Private Limited, Erba Diagnostics Mannheim GmbH, Hoffmann-La Roche Ltd, Medica Corporation, Nova Biomedical Corporation, Siemens Healthineers AG, Werfen SA, Radiometer Medical ApS, and Sensa Core Medical Instrumentation Pvt Ltd. are some of the leading companies operating in the Europe blood gas and electrolyte analyzer market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Blood Gas and Electrolyte Analyzer Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Europe Blood Gas and Electrolyte Analyzer Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Number of Patients in Emergency Units of Hospitals
    • 5.1.2 Rising Adoption of Point-of-Care Diagnostics
  • 5.2 Market Restraints
    • 5.2.1 High Costs of Analysers
  • 5.3 Market Opportunities
    • 5.3.1 New Product Launches and Approvals
  • 5.4 Future Trends
    • 5.4.1 Automation and Artificial Intelligence in Blood Gas and Electrolyte Analyzer
  • 5.5 Impact of Drivers and Restraints:

6. Blood Gas and Electrolyte Analyzer Market - Europe Market Analysis

  • 6.1 Europe Blood Gas and Electrolyte Analyzer Market Revenue (US$ Million), 2021-2031
  • 6.2 Blood Gas and Electrolyte Analyzer Market Forecast Analysis

7. Europe Blood Gas and Electrolyte Analyzer Market Analysis - by Product

  • 7.1 Blood Gas Analyzer
    • 7.1.1 Overview
    • 7.1.2 Blood Gas Analyzer: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Electrolyte Analyzer
    • 7.2.1 Overview
    • 7.2.2 Electrolyte Analyzer: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Combined Analyzer
    • 7.3.1 Overview
    • 7.3.2 Combined Analyzer: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Blood Gas and Electrolyte Analyzer Market Analysis - by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Overview
    • 8.1.2 Hospitals and Clinics: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Clinical and Diagnostic Laboratories
    • 8.2.1 Overview
    • 8.2.2 Clinical and Diagnostic Laboratories: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Homecare
    • 8.3.1 Overview
    • 8.3.2 Homecare: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Others
    • 8.4.1 Overview
    • 8.4.2 Others: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Blood Gas and Electrolyte Analyzer Market - Country Analysis

  • 9.1 Europe
    • 9.1.1 Europe: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast Analysis - by Country
      • 9.1.1.1 Europe: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast Analysis - by Country
      • 9.1.1.2 Germany: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.2.1 Germany: Blood Gas and Electrolyte Analyzer Market Breakdown, by Product
        • 9.1.1.2.2 Germany: Blood Gas and Electrolyte Analyzer Market Breakdown, by End User
      • 9.1.1.3 United Kingdom: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.3.1 United Kingdom: Blood Gas and Electrolyte Analyzer Market Breakdown, by Product
        • 9.1.1.3.2 United Kingdom: Blood Gas and Electrolyte Analyzer Market Breakdown, by End User
      • 9.1.1.4 France: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.4.1 France: Blood Gas and Electrolyte Analyzer Market Breakdown, by Product
        • 9.1.1.4.2 France: Blood Gas and Electrolyte Analyzer Market Breakdown, by End User
      • 9.1.1.5 Spain: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.5.1 Spain: Blood Gas and Electrolyte Analyzer Market Breakdown, by Product
        • 9.1.1.5.2 Spain: Blood Gas and Electrolyte Analyzer Market Breakdown, by End User
      • 9.1.1.6 Italy: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.6.1 Italy: Blood Gas and Electrolyte Analyzer Market Breakdown, by Product
        • 9.1.1.6.2 Italy: Blood Gas and Electrolyte Analyzer Market Breakdown, by End User
      • 9.1.1.7 Rest of Europe: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.7.1 Rest of Europe: Blood Gas and Electrolyte Analyzer Market Breakdown, by Product
        • 9.1.1.7.2 Rest of Europe: Blood Gas and Electrolyte Analyzer Market Breakdown, by End User

10. Industry Landscape

  • 10.1 Overview
  • 10.2 Organic Growth Strategies
    • 10.2.1 Overview
  • 10.3 Brand Share/Revenue- 2022

11. Company Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Dalko Diagnostics Private Limited
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Erba Diagnostics Mannheim GmbH
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Hoffmann-La Roche Ltd
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Medica Corporation
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Nova Biomedical Corporation
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Siemens Healthineers AG
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Werfen SA
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Radiometer Medical ApS
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Sensa Core Medical Instrumentation Pvt Ltd
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦